MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,726,682 | +20.7% | 62,596 | +0.1% | 0.01% | +20.0% |
Q2 2023 | $2,258,342 | -4.9% | 62,506 | -2.1% | 0.01% | -16.7% |
Q1 2023 | $2,374,761 | -17.9% | 63,872 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $2,894,041 | -36.6% | 63,872 | -2.2% | 0.01% | -41.7% |
Q3 2022 | $4,563,000 | +1.9% | 65,342 | -2.1% | 0.01% | +9.1% |
Q2 2022 | $4,480,000 | +19.3% | 66,742 | +46.1% | 0.01% | +57.1% |
Q1 2022 | $3,756,000 | -45.1% | 45,685 | -2.0% | 0.01% | -41.7% |
Q4 2021 | $6,841,000 | +14.1% | 46,633 | +37.6% | 0.01% | 0.0% |
Q3 2021 | $5,997,000 | +38.0% | 33,900 | +26.0% | 0.01% | +50.0% |
Q2 2021 | $4,346,000 | +54.6% | 26,903 | +64.0% | 0.01% | +33.3% |
Q1 2021 | $2,811,000 | -21.9% | 16,407 | +0.1% | 0.01% | -14.3% |
Q4 2020 | $3,601,000 | +37.2% | 16,397 | +3.7% | 0.01% | +16.7% |
Q3 2020 | $2,625,000 | +62.5% | 15,807 | +11.7% | 0.01% | +50.0% |
Q2 2020 | $1,615,000 | +57.3% | 14,147 | +5.9% | 0.00% | +33.3% |
Q1 2020 | $1,027,000 | -40.4% | 13,362 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $1,722,000 | +65.4% | 13,362 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $1,041,000 | -24.3% | 13,362 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $1,376,000 | +84.2% | 13,362 | +31.1% | 0.00% | +100.0% |
Q1 2019 | $747,000 | +77.9% | 10,192 | +2.9% | 0.00% | +100.0% |
Q4 2018 | $420,000 | +28.8% | 9,902 | +43.1% | 0.00% | 0.0% |
Q3 2018 | $326,000 | +18.1% | 6,920 | +23.8% | 0.00% | 0.0% |
Q2 2018 | $276,000 | – | 5,590 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |